Zealand Pharma and Boehringer Ingelheim Enter Into a Licence and Collaboration Agreement to Advance Novel Compounds to Treat Type-2 Diabetes a... ( COPENHAGEN Denmark and INGELHEIM Germ...)

HOME >> MEDICINE >> TECHNOLOGY

Zealand Pharma and Boehringer Ingelheim Enter Into a Licence and Collaboration Agreement to Advance Novel Compounds to Treat Type-2 Diabetes and Obesity

Date:6/15/2011

COPENHAGEN, Denmark and INGELHEIM, Germany, June 16, 2011 /PRNewswire/ --

- Boehringer Ingelheim Obtains Global Rights to glucagon/GLP-1 Dual Agonists, including ZP2929, Zealand Pharma's Lead Drug Candidate in This Class

- Zealand Pharma is Eligibleto Receive Total Projected Milestone Payments
of up to €376 million for ZP2929

Today, Zealand Pharma (NASDAQ OMX: ZEAL), a Copenhagen based biopharmaceutical company, and Boehringer Ingelheim, one of the world's leading pharmaceutical companies, jointly announced an exclusive global licence and collaboration agreement for dual-acting glucagon and GLP-1 receptor agonists for the treatment of patients with Type-2 diabetes and patients with obesity.

As part of the agreement, Boehringer Ingelheim obtains global development and commercialisation rights to ZP2929, Zealand Pharma's lead glucagon/GLP-1 dual agonist drug candidate. Zealand Pharma will be responsible for conducting the first Phase I study with ZP2929 and Boehringer Ingelheim will fund the research, development and commercialisation of products under the agreement.

Depending on the achievement of pre-defined development, regulatory and commercial milestones, Zealand Pharma is eligible to receive payments for ZP2929 and may also receive additional milestone payments if other products covered by the collaboration are advanced through development. Further, Zealand Pharma is entitled to tiered royalties that range from high single to low double digits on global sales of products under the agreement. Zealand Pharma retains co-promotion rights in Scandinavia.

During the first two years of collaboration, Zealand Pharma is eligible to receive sig
'/>"/>

SOURCE Zealand Pharma A/S
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5
Related medicine technology :

1. NxStage® Advances Global Growth Strategy with System One™ Regulatory Approval and Distribution Agreement in Australia and New Zealand
2. Prostate Cancer Patients Benefit from New Zealand Centers Adoption of Elekta VMAT Radiotherapy Technique
3. Cumberland Pharmaceuticals and Phebra Pty Ltd. Sign Exclusive Agreement for Commercialization of Caldolor(R) in Australia and New Zealand
4. Successful Clinical Trials and Launch in New Zealand Spurs Phloe to Enter US Market
5. Dr. Assad Al-Ammar Joins Irvine Pharmaceutical Services as the New Minerals Analysis Manager in Response to the Growing Needs for USP Elemental Impurities Testing
6. ViroPharmas Cinryze® (C1 Inhibitor [Human]) Granted European Marketing Authorization for Hereditary Angioedema (HAE)
7. Saint-Gobains New C-Flex® ULTRA Pump Tubing for Biopharmaceutical Applications Outperforms the Competition
8. Inovio Pharmaceuticals to Present at Scientific & Industry Conferences
9. Neurelis Announces Positive Results from Phase 1 Pharmacokinetic Study of NRL-01 (intranasal diazepam)
10. Caraco Announces Stockholder Approval of Merger Agreement with Sun Pharma and Consummation of the Merger
11. Cardinal Health Extends Radiopharmaceutical Manufacturing Network, Opening its First Cyclotron in Georgia

Post Your Comments:

(Date:6/18/2013)... , June 18, 2013 In a letter to ... , M.D., of Lake View, Iowa , ... receive annual influenza vaccine is neither scientifically justified nor ethically ... article in the summer issue of the Journal ... official statistics are correct, and an average of 36,000 patients ...

(Date:6/18/2013)... Decision Resources, one of the world,s leading research and advisory ... past 12 months, 25 percent of surveyed physicians from the ... , Italy , Spain ... been required to change the antiretroviral (ARV) prescription for some ... Additionally, more than 40 percent of respondents report that changing ...

(Date:6/18/2013)... June 18, 2013 New-generation electronic designs ... portable and lightweight. Simultaneously, circuitry is increasing the ... speed to which it performs at. Connecting cables ... and military equipment, such as cameras or detectors, ... and nano-circular connectors include custom cable designs for ...

Breaking Medicine Technology:Mandated Flu Vaccine for Hospital Workers Ethically Questionable, Surgeon Writes 2 One in Four Surveyed EU5 Physicians Has Been Required to Change a Prescription for Some or Most of Their HIV Patients in the Past Twelve Months, Primarily to Reduce Costs 2 One in Four Surveyed EU5 Physicians Has Been Required to Change a Prescription for Some or Most of Their HIV Patients in the Past Twelve Months, Primarily to Reduce Costs 3 Omnetics Circular Connectors Offer Both Micro and Nano Interconnects for Highly Portable Electronic Systems, Meeting the Needs of Designers Looking for Size Reduction Options and Cable Flexibility 2

[0] Mandated Flu Vaccine for Hospital Workers Ethically Questionable, Surgeon Writes [0] One in Four Surveyed EU5 Physicians Has Been Required to Change a Prescription for Some or Most of Their HIV Patients in the Past Twelve Months, Primarily to Reduce Costs [0] Omnetics Circular Connectors Offer Both Micro and Nano Interconnects for Highly Portable Electronic Systems, Meeting the Needs of Designers Looking for Size Reduction Options and Cable Flexibility

... , ABBOTT PARK, Ill., Nov. 12 Nearly one in ... normal and nearly 34 million have low HDL "good" cholesterol ... HDL and trigs, Abbott has launched two Web sites: ... , "Unhealthy high triglyceride and low HDL levels are factors ...

... a leader in fluorescence in vivo imaging from ... new Cat B 750 FAST(TM) imaging agent for ... and therapeutic response in vivo . Cathepsin B ... target in a range of diseases, including atherosclerosis, oncology, and ...

Cached Medicine Technology:New Web Sites Educate About Triglycerides and HDL Cholesterol 2 VisEn Launches New Cat B 750 Fast(TM) Fluorescence Molecular Imaging Agent at American Heart Association Meeting 2 VisEn Launches New Cat B 750 Fast(TM) Fluorescence Molecular Imaging Agent at American Heart Association Meeting 3

New Web Sites Educate About Triglycerides and HDL Cholesterol VisEn Launches New Cat B 750 Fast(TM) Fluorescence Molecular Imaging Agent at American Heart Association Meeting

(Date:6/18/2013)... have discovered and mapped the signaling network between two ... could cut off cancer cell growth at its starting ... University of Texas MD Anderson Cancer Center reported the ... cancer drug target, and MCM7, a protein vital to ... issue of Cancer Cell . , "MCM7 overexpression ...

(Date:6/18/2013)... (PRWEB) June 18, 2013 The July 2013 ... Cheater’s Guide to Getting Beach Ready,” offers a list of ... look their best in a bathing suit this summer. The ... skin firming , smoothing cellulite , and more. (go ... Ourian, Medical Director of Epione Beverly Hills, “though I would ...

(Date:6/18/2013)... June 18, 2013 myCNAjobs announces the ... free downloads, articles, and tips to the Caregiver Resources ... care for the 10,000+ retiring baby boomers each day, ... caregiver job resources has never been greater. ... job community, recently launched the first-ever free resource ...

(Date:6/18/2013)... June 18, 2013 Healthcare ... ScripNet and Procura Management, today announced the appointment ... sales officer. In this position, Leonardo will direct ... the company’s strategic growth initiatives. , Recognized in ... and expertise, Leonardo brings more than 20 years ...

(Date:6/18/2013)... June 18, 2013 Today, Zane Benefits, ... Reimbursement Accounts . Zane Benefits, which provides comprehensive and ... the leader in defined contribution and ... Benefits’ website, employees of a company who sets up ... questions about how Health Reimbursement Accounts work. Educating employees ...

Breaking Medicine News(10 mins):Health News:Scientists catch EGFR passing a crucial message to cancer-promoting protein 2 Health News:Skin Care – Getting Your Body Beach Ready 2 Health News:myCNAjobs Adds New Resources to Growing Caregiver Career Center 2 Health News:Healthcare Solutions Appoints Richard Leonardo to Chief Sales Officer 2 Health News:Zane Benefits Publishes New Information on Health Reimbursement Accounts 2

[0] Scientists catch EGFR passing a crucial message to cancer-promoting protein [0] Skin Care – Getting Your Body Beach Ready [0] myCNAjobs Adds New Resources to Growing Caregiver Career Center [0] Healthcare Solutions Appoints Richard Leonardo to Chief Sales Officer [0] Zane Benefits Publishes New Information on Health Reimbursement Accounts

... 8 Pieris AG,a biopharmaceutical company developing Anticalins(R), ... announced the appointment of Dr,Angelika Stern as Chief ... the promotion with immediate effect of Dr Andreas ... Preclinical Development to Chief,Technology Officer. The appointment ...

... November 8 - Healthcare Businesswomen,s ... Groundbreaking Study and Best Practices for,Recruitment, Retention, ... the highly anticipated Healthcare Businesswomen,s,Association (HBA) E.D.G.E. ... exceeded the expectations of pharmaceutical senior,management, who ...

... Cell Therapeutics, Inc. (CTI),(Nasdaq and MTAX: CTIC) today reported recent ... September 30, 2007. Recent Events, -- Announced agreement ... first FDA-approved radioimmunotherapy, from Biogen Idec; this ... group of only a few biotech ...

... - Revenue for the third quarter was $464.6 million, Facility Operating ... - Average occupancy for the quarter was 90.8%, and average revenue per, ... ... quarter.,- Cash From Facility Operations for the quarter was $43.3 million, or $0.43, ...

... Leader Joins Healthcare ... Management Consulting Practice, SANTA ANA, Calif., ... appointment of Ogan Gurel, M.D. as a Managing,Director with its ... join our team," said Vip Jain - Principal and,Head of ...

... Inc. (OTC,Bulletin Board: GOVX), an Atlanta based biotechnology ... Ph.D. has been elected,"Fellow of the American Association ... "Fellow" is an honor bestowed upon AAAS members ... science or its,applications. Emory University professor and Asa ...

Pieris Strengthens its Management, as it Prepares for the Clinical Development of PRS-050, an Anticalin(R)-Based Novel Cancer Therapy E.D.G.E. in Leadership Study Delivers First-Ever Data on Executive Women in Pharmaceutical and Biotech Industries Cell Therapeutics, Inc. (CTI) Reports Recent Accomplishments and Third Quarter 2007 Financial Results Brookdale Announces Third Quarter 2007 Results XRoads Solutions Group Appoints Dr. Ogan Gurel as Managing Director GeoVax Co-Founder Dr. Harriet Robinson Named 2007 AAAS Fellow

Bi-Directional doppler volume flowmeter....

... frequency and multigate transcranial ... and fitted with a ... for hemodynamic evaluation. Looki ... well for routine diagnosis ...

One channel, one gate transcranial Doppler that is diagnosis oriented with an advanced protocol editor, automatic report generator and a powerful examination data base....

One channel transcranial Doppler...

Medicine Products:

DVM-4300T Transcranial Doppler Looki 2TC Looki TCD Basic TCD